Recently, the effect of m7G RNA methylation regulators on glioma prognosis has been investigated, where three genes (NUDT7, NUDT11 and CYFIP2) have been proposed as promising prognostic biomarkers for gliomas [62]. This evidence concerns the gene NUDT7 and glioma.